Intellia Therapeutics, Inc. (NTLA)
9.705
-0.84
(-8.01%)
USD |
NASDAQ |
Nov 13, 16:00
9.82
+0.12
(+1.18%)
After-Hours: 19:59
Intellia Therapeutics Gross Profit Margin (Quarterly) : 73.15% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 73.15% |
| June 30, 2026 | 72.58% |
| March 31, 2026 | 85.37% |
| December 31, 2025 | 73.87% |
| September 30, 2025 | 64.19% |
| June 30, 2025 | 82.45% |
| March 31, 2025 | 84.98% |
| December 31, 2024 | 80.07% |
| September 30, 2024 | 71.38% |
| June 30, 2024 | 62.64% |
| March 31, 2024 | 91.32% |
| December 31, 2023 | |
| September 30, 2023 | 80.90% |
| June 30, 2023 | 84.04% |
| March 31, 2023 | 83.74% |
| December 31, 2022 | 85.04% |
| September 30, 2022 | 85.30% |
| June 30, 2022 | 86.91% |
| March 31, 2022 | 84.41% |
| December 31, 2021 | 85.37% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Twist Bioscience Corp. | 52.76% |
| Beam Therapeutics, Inc. | -1.67K% |
| Prime Medicine, Inc. | -54.68% |
| 10X Genomics, Inc. | 75.52% |
| Moderna, Inc. | 70.60% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.01% |
| Return on Assets | -49.71% |
| Return on Invested Capital | -53.85% |
| Profit Margin (Quarterly) | -1.78K% |
| Operating Margin (Quarterly) | -1.71K% |
| Return on Net Operating Assets | -254.0% |